CIK 0001088856 · Large accelerated filer
CORCEPT THERAPEUTICS INC
Sign in to watch- Ticker
- CORT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770487658
- Phone
- 650.688.8803
- Business address
- 101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,067,988
- in 15 filings, $36.6M under 10b5-1 plans
Net −$41,067,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-02 | Mokari Atabak Chief Financial Officer | Grant or award | +775 | $71.68 | $56K | 13,809 |
| 2025-06-02 | Mokari Atabak Chief Financial Officer | Grant or award | +775 | 14,584 | ||
| 2025-05-29 | Maduck Sean See Remarks | Option exercise | +10,000 | $3.88 | $39K | 25,929 |
| 2025-05-29 | Maduck Sean See Remarks | Gift | −10,000 | 15,929 | ||
| 2025-05-29 | Maduck Sean See Remarks | Other acquisition | +10,000 | 89,693 | ||
| 2025-05-29 | Maduck Sean See Remarks | Option exercise · Stock option (right to buy) | −10,000 | 0 | ||
| 2025-05-20 | Robb Gary Charles Chief Business Officer | Sale | −2,279 | $75.85 | $173K | 16,586 |
| 2025-05-20 | Robb Gary Charles Chief Business Officer | Gift | −1,380 | 15,206 | ||
| 2025-05-20 | Robb Gary Charles Chief Business Officer | Gift | +360 | 11,571 | ||
| 2025-05-20 | Robb Gary Charles Chief Business Officer | Gift | +360 | 11,571 | ||
| 2025-05-16 | Guyer William Chief Development Officer | Option exercise 10b5-1 | +32,262 | $21.65 | $698K | 37,749 |
| 2025-05-16 | Guyer William Chief Development Officer | Sale 10b5-1 | −32,262 | $74.17 | $2.4M | 5,487 |
| 2025-05-16 | Guyer William Chief Development Officer | Option exercise · Stock option (right to buy) 10b5-1 | −32,262 | 410,000 | ||
| 2025-05-16 | MAHONEY DAVID L Director | Option exercise | +30,000 | $6.55 | $197K | 30,000 |
| 2025-05-16 | MAHONEY DAVID L Director | Shares withheld for taxes | −2,648 | $74.21 | $197K | 27,352 |
| 2025-05-16 | MAHONEY DAVID L Director | Sale | −23,829 | $74.17 | $1.8M | 3,523 |
| 2025-05-16 | MAHONEY DAVID L Director | Sale | −3,523 | $74.65 | $263K | 0 |
| 2025-05-16 | MAHONEY DAVID L Director | Option exercise · Stock option (right to buy) | −30,000 | 0 | ||
| 2025-05-12 | Swisher Daniel N JR Director | Option exercise 10b5-1 | +1,800 | $12.13 | $22K | 1,800 |
| 2025-05-12 | Swisher Daniel N JR Director | Option exercise 10b5-1 | +400 | $14.08 | $6K | 2,200 |
Page 26 of 61 · 1,220 trades